Some menstrual variation during weight loss may be expected, but contact your GP if you miss three consecutive periods, experience unusually heavy bleeding, or have other concerning symptoms for proper evaluation
[21] A clinician may need to review and adjust these medicines if retatrutide or a similar agent is introduced
The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration
However, the financial burden, especially without insurance, can be significant
Retatrutide is a multi-pathway metabolic research peptide developed for research work in energy regulation signaling associated with energy balance, nutrient utilization, and regulatory pathway interactions in controlled laboratory settings
Ideally, use an FDA-cleared sharps disposal container, otherwise dispose of the pen in a plastic container with a tight-fitting, puncture-resistant lid
